Prof Katherine Payne PhD, MSc, DipClinPharm, BPharm, FRPharmS

Professor of Health Economics

Full contact details
View graph of relations

Research interests

Katherine has over 20 years experience as an academic health economist and an international reputation for the economics of precision medicine and genomic technologies and services. Katherine has established a number of innovative research collaborations with genomics and other clinical colleagues. Ongoing and recent projects include: evaluation of information provision and models of informed consent in bloodspot newborn screening programmes; identifying and costing pathways of care for people with ataxia; building economic model to identify the most appropriate interval for breast cancer screening; preliminary economic evaluation of high-throughput whole genome sequencing technologies; towards HTA of whole genome sequencing; economic evaluation of risk stratified breast screening programmes; and various economic evaluations of examples of stratified medicines (funded by NIHR HTA; NIHR Research for Patient Benefit; NIHR Programme Grants for Applied Research; EU Framework Seven; Department of Health; MRC).

Methodological knowledge

Model-based and prospective economic evaluations

Stated preference methods including discrete choice experiments and contingent valuation

Valuing health and non-health outcomes


Research and projects